-
Something wrong with this record ?
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease
E. Mezeiova, J. Janockova, R. Andrys, O. Soukup, T. Kobrlova, L. Muckova, J. Pejchal, M. Simunkova, J. Handl, P. Micankova, J. Capek, T. Rousar, M. Hrabinova, E. Nepovimova, JL. Marco-Contelles, M. Valko, J. Korabecny
Language English Country France
Document type Journal Article
- MeSH
- Alzheimer Disease drug therapy MeSH
- Humans MeSH
- Naphthoquinones pharmacology therapeutic use MeSH
- Drug Design MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks. The concept of "one drug, one target" has not generated any new drugs since 2004. The new era of drug development in the field of AD builds upon rationally designed multi-target directed ligands that can better address the complexity of AD. Herewith, we designed ten novel derivatives of 2-propargylamino-naphthoquinone. The biological evaluation of these compounds includes inhibition of monoamine oxidase A/B, inhibition of amyloid-beta aggregation, radical-scavenging, and metal-chelating properties. Some of the compounds possess low cytotoxicity profile with an anti-inflammatory ability in the lipopolysaccharide-stimulated cellular model. All these features warrant their further testing in the field of AD.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019274
- 003
- CZ-PrNML
- 005
- 20221024102112.0
- 007
- ta
- 008
- 210728s2021 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2020.113112 $2 doi
- 035 __
- $a (PubMed)33360800
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Mezeiová, Eva $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $7 xx0277560
- 245 10
- $a 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease / $c E. Mezeiova, J. Janockova, R. Andrys, O. Soukup, T. Kobrlova, L. Muckova, J. Pejchal, M. Simunkova, J. Handl, P. Micankova, J. Capek, T. Rousar, M. Hrabinova, E. Nepovimova, JL. Marco-Contelles, M. Valko, J. Korabecny
- 520 9_
- $a Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks. The concept of "one drug, one target" has not generated any new drugs since 2004. The new era of drug development in the field of AD builds upon rationally designed multi-target directed ligands that can better address the complexity of AD. Herewith, we designed ten novel derivatives of 2-propargylamino-naphthoquinone. The biological evaluation of these compounds includes inhibition of monoamine oxidase A/B, inhibition of amyloid-beta aggregation, radical-scavenging, and metal-chelating properties. Some of the compounds possess low cytotoxicity profile with an anti-inflammatory ability in the lipopolysaccharide-stimulated cellular model. All these features warrant their further testing in the field of AD.
- 650 _2
- $a Alzheimerova nemoc $x farmakoterapie $7 D000544
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a naftochinony $x farmakologie $x terapeutické užití $7 D009285
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Janockova, Jana $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Andrys, Rudolf $u University Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
- 700 1_
- $a Soukup, Ondrej $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Kobrlová, Tereza, $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $d 1991- $7 xx0277928
- 700 1_
- $a Muckova, Lubica $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Pejchal, Jaroslav $u University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Simunkova, Miriama $u Slovak University of Technology, Faculty of Chemical and Food Technology, Radlinskeho 9, 812 37, Bratislava, Slovakia
- 700 1_
- $a Handl, Jiri $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
- 700 1_
- $a Micankova, Petra $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
- 700 1_
- $a Capek, Jan $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
- 700 1_
- $a Rousar, Tomas $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
- 700 1_
- $a Hrabinova, Martina $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Nepovimova, Eugenie $u University Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
- 700 1_
- $a Marco-Contelles, Jose Luis $u Institute of General Organic Chemistry, Laboratory of Medicinal Chemistry, Juan de La Cierva 3, 28006, Madrid, Spain. Electronic address: jlmarco@iqog.csic.es
- 700 1_
- $a Valko, Marian $u Slovak University of Technology, Faculty of Chemical and Food Technology, Radlinskeho 9, 812 37, Bratislava, Slovakia. Electronic address: marian.valko@stuba.sk
- 700 1_
- $a Korabecny, Jan $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic. Electronic address: jan.korabecny@fnhk.cz
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 211, č. - (2021), s. 113112
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33360800 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20221024102110 $b ABA008
- 999 __
- $a ok $b bmc $g 1690165 $s 1139720
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 211 $c - $d 113112 $e 20201218 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20210728